JAGX - Jaguar Health Inc
IEX Last Trade
1.135
0.015 1.322%
Share volume: 172,775
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.12
0.02
1.34%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-22 | 2022-11-14 | 2023-03-24 | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-04-01 | 2024-05-14 | |
| Assets | |||||||||
| Total Assets | 49.885 M | 51.287 M | 47.452 M | 56.927 M | 52.172 M | 45.380 M | 50.763 M | 55.389 M | |
| Current Assets | 23.362 M | 25.208 M | 22.321 M | 32.361 M | 28.227 M | 22.059 M | 27.963 M | 33.714 M | |
| Inventories | 6.745 M | 6.601 M | 7.024 M | 8.684 M | 8.264 M | 8.379 M | 9.189 M | 9.020 M | |
| Other Current Assets | 5.528 M | 5.587 M | 7.361 M | 7.866 M | 9.778 M | 8.609 M | 10.121 M | 11.309 M | |
| Short Term Investments | 5.528 M | 5.587 M | 7.361 M | 7.866 M | 9.778 M | 8.609 M | 10.121 M | 11.309 M | |
| Total Receivables | 2.075 M | 2.459 M | 2.467 M | 1.444 M | 1.558 M | 1.845 M | 2.184 M | 1.714 M | |
| Current Cash | 9.014 M | 10.561 M | 5.469 M | 14.367 M | 8.627 M | 3.226 M | 6.469 M | 11.671 M | |
| Total Non-current Assets | 26.523 M | 26.079 M | 25.131 M | 24.566 M | 23.945 M | 23.321 M | 22.800 M | 21.675 M | |
| Property Plant Equipment | 583.000 K | 572.000 K | 557.000 K | 541.000 K | 526.000 K | 511.000 K | 496.000 K | 484.000 K | |
| Other Assets | 1.754 M | 1.842 M | 995.000 K | 1.012 M | 1.011 M | 1.012 M | 1.012 M | 275.000 K | |
| Intangible Assets | 22.991 M | 22.561 M | 22.439 M | 21.951 M | 21.463 M | 20.974 M | 20.116 M | 19.627 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 49.885 M | 51.287 M | 47.452 M | 56.927 M | 52.172 M | 45.380 M | 50.763 M | 55.389 M | |
| Total liabilities | 47.169 M | 47.640 M | 48.109 M | 49.577 M | 46.535 M | 44.020 M | 45.802 M | 40.906 M | |
| Total current liabilities | 22.901 M | 26.944 M | 30.339 M | 31.096 M | 29.003 M | 12.456 M | 13.987 M | 17.814 M | |
| Accounts Payable | 5.645 M | 6.285 M | 5.808 M | 5.692 M | 4.663 M | 5.133 M | 4.974 M | 3.320 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 680.000 K | |
| Current long term debt | 7.953 M | 11.737 M | 15.883 M | 15.621 M | 13.807 M | 3.509 M | 4.867 M | 10.394 M | |
| Long term debt | 23.359 M | 20.006 M | 17.744 M | 17.544 M | 16.846 M | 31.157 M | 30.993 M | 21.719 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 680.000 K | |
| Minority interest | 41.000 K | -48.000 K | -699.000 K | 310.000 K | 191.000 K | 56.000 K | -64.000 K | -180.000 K | |
| Total Shareholder equity | 2.716 M | 3.647 M | -657.000 K | 7.350 M | 5.637 M | 1.360 M | 4.961 M | 14.483 M | |
| Common stock | 79.699 M | 1.418 M | -3.007 M | 5.110 M | 17.632 M | 20.739 M | 48.793 M | 158.842 M | |
| Retained earnings | -246.847 M | -259.367 M | -266.948 M | -279.150 M | -291.300 M | -299.079 M | -308.248 M | -317.215 M |